Professor of Neurology, University Tex Houston
Neurology
Dr. James C. Grotta, MD
|
|
Give Review
Dr. James C. Grotta works in the field of Neurology. He graduated from University of Virginia School of Medicine. He received 5 awards: "America's Top Doctors", "Top Doctors:SE Texas", "Meaningful Use Stage 1 Certification", "Super Doctor" and "Top MD". James Grotta is a published MD. He published 101 publications, including: 'Swipe out Stroke: Feasibility and efficacy of using a smart-phone based mobile application to improve compliance with weight loss in obese minority stroke patients and...' He is registered with Medicare and accepts Medicare payments.
Publications
- Swipe out Stroke: Feasibility and efficacy of using a smart-phone based mobile application to improve compliance with weight loss in obese minority stroke patients and...
- Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011.
- Benefits of Stroke Treatment Using a Mobile Stroke Unit Compared With Standard Management: The BEST-MSU Study Run-In Phase.
- Establishing the First Mobile Stroke Unit in the United States.
- Is the ICH score a valid predictor of mortality in intraCerebral hemorrhage?
- Telemedicine-guided remote enrollment of patients into an acute stroke trial.
- Decompressive hemicraniectomy with or without clot evacuation for large spontaneous supratentorial intraCerebral hemorrhages.
- Implementing a Mobile Stroke Unit Program in the United States: Why, How, and How Much?
- RNF213 Rare Variants in an Ethnically Diverse Population With Moyamoya Disease.
- Comparison Between a Standardized Questionnaire and Expert Clinicians for Capacity Assessment in Stroke Clinical Trials.
- Intravenous fibrinolysis eligibility: a survey of stroke clinicians' practice patterns and review of the literature.
- Prehospital Utility of Rapid Stroke Evaluation Using In-Ambulance Telemedicine: A Pilot Feasibility Study.
- CTP infarct core may predict poor outcome in stroke patients treated with IV t-PA.
- Thrombelastography detects the anticoagulant effect of rivaroxaban in patients with stroke.
- Thrombelastography detects possible coagulation disturbance in patients with intraCerebral hemorrhage with hematoma enlargement.
- Racial and Gender Differences in Stroke Severity, Outcomes, and Treatment in Patients with Acute Ischemic Stroke.
- Stroke: new horizons in treatment.
- Iodinated Contrast Does Not Alter Clotting Dynamics in Acute Ischemic Stroke as Measured by Thromboelastography.
- CLOTBUST-Hands Free: Pilot Safety Study of a Novel Operator-Independent Ultrasound Device in Patients With Acute Ischemic Stroke.
- Therapeutic Time Window and Dose Dependence of Xenon Delivered via Echogenic Liposomes for Neuroprotection in Stroke.
- The NIHSS Score and its Components can Predict Cortical Stroke.
- Clinical practice. Carotid stenosis.
- The NINDS Stroke Progress Review Group Final Analysis and Recommendations.
- Optimizing Prediction Scores for Poor Outcome After Intra-Arterial Therapy in Anterior Circulation Acute Ischemic Stroke.
- Design of a prospective, dose-escalation study evaluating the Safety of Pioglitazone for Hematoma Resolution in IntraCerebral Hemorrhage (SHRINC).
- Acute Stroke Imaging Research Roadmap II.
- Adjunctive Medical Therapies for Acute Stroke Thrombolysis: Is There a CLEAR-ER Choice?
- CLOTBUST-Hands Free: Initial Safety Testing of a Novel Operator-Independent Ultrasound Device in Stroke-Free Volunteers.
- Changing demographics at a comprehensive stroke center amidst the rise in primary stroke centers.
- Posterior circulation stroke is associated with prolonged door-to-needle time.
- Hypothermia for acute ischaemic stroke.
- Stroke severity as well as time should determine stroke patient triage.
- Changes in spleen size in patients with acute ischemic stroke: a pilot observational study.
- Defining Intravenous Recombinant Tissue Plasminogen Activator Failure.
- Patient refusal of thrombolytic therapy for suspected acute ischemic stroke.
- Hospital-Acquired Symptomatic Urinary Tract Infection in Patients Admitted to an Academic Stroke Center Affects Discharge Disposition.
- Thromboelastography in patients with acute ischemic stroke.
- Reprint: frank m. Yatsu, m.d.
- Frank michio yatsu, MD.
- The interaction of aspiration pneumonia with demographic and cerebrovascular Disease risk factors is predictive of discharge level of care in acute stroke patient.
- The Argatroban and Tissue-Type Plasminogen Activator Stroke Study: Final Results of a Pilot Safety Study.
- The Interaction of Aspiration Pneumonia with Demographic and Cerebrovascular Disease Risk Factors is Predictive of Discharge Level of Care in the Acute Stroke Patient.
- Intracranial AtheroSclerosis Is Associated with Progression of Neurological Deficit in Subcortical Stroke.
- Inflammatory response to intraventricular Hemorrhage: Time course, magnitude and effect of t-PA.
- Systemic Thrombolysis in Patients With Acute Ischemic Stroke and Internal Carotid ARtery Occlusion: The ICARO Study.
- Intravenous autologous bone marrow mononuclear cells for ischemic stroke.
- Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke.
- Pharmacological deep vein thrombosis prophylaxis does not lead to hematoma expansion in intraCerebral hemorrhage with intraventricular extension.
- Thrombolysis with intravenous tissue plasminogen activator predicts a favorable discharge disposition in patients with acute ischemic stroke.
- Zero on the NIHSS does not equal the absence of stroke.
- Stroke treatment and prevention: five new things.
- Increased blood-Brain barrier permeability on perfusion CT might predict malignant middle cerebral artery infarction.
- AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke.
- Bone marrow mononuclear cells protect neurons and modulate microglia in cell culture models of ischemic stroke.
- IntraCerebral hemorrhage: introduction.
- Feasibility of Carotid artery stenting in patients with angiographic string sign.
- Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model.
- IntraCerebral hemorrhage in cocaine users.
- Caffeinol at the receptor level: anti-ischemic effect of N-methyl-D-aspartate receptor blockade is potentiated by caffeine.
- Kids Identifying and Defeating Stroke (KIDS): development and implementation of a multiethnic health education intervention to increase stroke awareness among middle s...
- Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats.
- Neuroprotective role of haptoglobin after intraCerebral hemorrhage.
- Intravenous tissue plasminogen activator in patients with cocaine-associated acute ischemic stroke.
- Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial.
- Neuronal PPARgamma deficiency increases susceptibility to Brain damage after cerebral ischemia.
- Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery Disease, stroke, and Moyamoya Disease, along with thoracic aortic Disease.
- Is the drip-and-ship approach to delivering thrombolysis for acute ischemic stroke safe?
- 26th Princeton Conference on Cerebrovascular Disease: Preface.
- Thrombolytic therapy for patients who wake-up with stroke.
- The IVH score: a novel tool for estimating intraventricular Hemorrhage volume: clinical and research implications.
- Combined neuroprotective modalities coupled with thrombolysis in acute ischemic stroke: a pilot study of caffeinol and mild hypothermia.
- Does study enrollment delay treatment with intravenous thrombolytics for acute ischemic stroke?
- Thrombus burden is associated with clinical outcome after intra-arterial therapy for acute ischemic stroke.
- Anticoagulation after cardioembolic stroke: to bridge or not to bridge?
- Aggressive blood Pressure-lowering treatment before intravenous tissue plasminogen activator therapy in acute ischemic stroke.
- A pilot randomized clinical safety study of sonothrombolysis augmentation with ultrasound-activated perflutren-lipid microspheres for acute ischemic stroke.
- Antiplatelet therapy and the risk of intracranial Hemorrhage after intravenous tissue plasminogen activator therapy for acute ischemic stroke.
- Stroke program review group: an interim report.
- The effect of activated factor VII for intraCerebral hemorrhage beyond 3 hours versus within 3 hours.
- LOAD: a pilot study of the safety of loading of aspirin and clopidogrel in acute ischemic stroke and transient ischemic attack.
- Transcription factor Nrf2 protects the Brain from damage produced by intracerebral hemorrhage.
- A randomized, controlled trial to teach middle school children to recognize stroke and call 911: the kids identifying and defeating stroke project.
- Hematoma resolution as a target for intraCerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages.
- Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?
- Constraint-induced movement therapy during early stroke rehabilitation.
- Safety outcomes of Alteplase among acute ischemic stroke patients with special characteristics.
- Kids Identifying and Defeating Stroke (KIDS): design of a school-based intervention to improve stroke awareness.
- Argatroban tPA stroke study: study design and results in the first treated cohort.
- 15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and...
- Using telemedicine to facilitate thrombolytic therapy for patients with acute stroke.
- Telemedicine-guided Carotid and transcranial ultrasound: a pilot feasibility study.
- Latest advances in intraCerebral hemorrhage.
- Endovascular recanalization of internal Carotid artery occlusion in acute ischemic stroke.
- Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO).
- Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke?
- New era for management of primary hypertensive intraCerebral hemorrhage.
- Yield and accuracy of urgent combined Carotid/transcranial ultrasound testing in acute cerebral ischemia.
- Combining insulin-like growth factor derivatives plus caffeinol produces robust neuroprotection after stroke in rats.
- Constraint-induced movement therapy.
- Management of Primary Hypertensive Hemorrhage of the Brain.
Schools
University Of Virginia School Of Medicine
Ny Hospital Cornell
University Of Colorado
Massachusetts General Hospital
Dartmouth
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Autonomic Disorders
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Vascular Neurology
- Neurology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- Meaningful Use Stage 1 Certification
- Super Doctor
- Top MD
Education
-
Massachusetts General Hospital -
University of Colorado -
New York Presbyterian Hospital - Cornell Campus -
University of Virginia School of Medicine
Hospital
-
Baylor St. Luke's Medical Center
Drug Facts
| NPI NUMBER | 1861422404 | |
| NPPES Provider LastName | GROTTA | |
| NPPES Provider FirstName | JAMES | |
| NPPES Provider ZIPCode | 770303000 | |
| NPPES Provider State | TX | |
| Specialty Description | Neurology | |
| Total Claim Count | 287.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861422404 |
| Last Name Of The Provider | GROTTA |
| First Name Of The Provider | JAMES |
| View All |
Similar Doctors
|
Dr. Sean I. Savitz, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. William G. Ondo, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. John J. Volpi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nelson A. Berrios, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laura P. Masters, MD |
|
|
Dr. Pitchaiah Mandava, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roderic H. Fabian, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nicole R. Gonzales, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Suresh Roongta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James M. Killian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sharyl R. Martini, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rahul R. Karamchandani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David T. Doan, MD |
|
|
Dr. Amanda L. Jagolino, MD |